Multi-resistant bacteria kill tens of thousands in Europe as the antibiotics don't work. New types are less profitable to develop, so it is not done. Faced with the third biggest threat to public heal...

Pharmaceutical industry pours €110 million into advocacy organisations across the continent, Investigate Europe research reveals. Critics argue that funding threatens “independence” of the sector, cla...

Days after our investigation into the European Medicines Agency, the European Commission ordered the re-examination of a drug which the medicines regulator had controversially rejected for authorisati...

How big pharma feeds inequality in Europe

Investigate Europe finds 15 of the world’s biggest drugmakers operate more than 1,300 subsidiaries in low-tax territories. These structures helped them amass €580 billion in profits in the past five y...

The European Medicines Agency is beset by several conflicts of interest with concerns over professional and financial ties to industry. It is also facing growing criticism for fast-tracking drugs that...

Multi-resistant bacteria kill tens of thousands in Europe as the antibiotics don't work. New types are less profitable to develop, so it is not done. Faced with the third biggest threat to public heal...

Für Medikamente ohne Zusatznutzen zahlen deutsche Krankenkassen oft nur einen Bruchteil des Listenpreises. Die Abschläge wollen Konzerne gegenüber anderen Ländern gerne verheimlichen. Der Gesundheitsm...